Details Basic Details Approval Date Tuesday, October 17, 2023 Original Posting Date Friday, December 29, 2023 Health Outcome(s) adverse pregnancy and fetal outcomes, drug induced liver injury, hematologic adverse reactions, hepatitis B reactivation, hypersensitivity reactions, inflammatory bowel disease (IBD), major adverse cardiovascular events, malignancy, opportunistic infections, serious infections, tuberculosis (TB) Regulatory Link(s) (2) FDA Approval Package ARIA Memo